Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?

Losina E, Burbine SA, Suter LG, Hunter DJ, Solomon DH, Daigle ME, Dervan EE, Jordan JM, Katz JN.

Osteoarthritis Cartilage. 2014 Mar;22(3):415-30. doi: 10.1016/j.joca.2014.01.005. Epub 2014 Jan 31.

PMID:
24487044
[PubMed - in process]
2.

Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

Losina E, Daigle ME, Suter LG, Hunter DJ, Solomon DH, Walensky RP, Jordan JM, Burbine SA, Paltiel AD, Katz JN.

Osteoarthritis Cartilage. 2013 May;21(5):655-67. doi: 10.1016/j.joca.2013.01.016. Epub 2013 Feb 4.

PMID:
23380251
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.

Rampersaud YR, Tso P, Walker KR, Lewis SJ, Davey JR, Mahomed NN, Coyte PC.

Spine J. 2014 Feb 1;14(2):244-54. doi: 10.1016/j.spinee.2013.11.011. Epub 2013 Nov 12.

PMID:
24239803
[PubMed - in process]
5.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

PMID:
16545208
[PubMed - indexed for MEDLINE]
Free Article
6.

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.

PMID:
18405470
[PubMed - indexed for MEDLINE]
Free Article
7.

Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume.

Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN.

Arch Intern Med. 2009 Jun 22;169(12):1113-21; discussion 1121-2. doi: 10.1001/archinternmed.2009.136. Review.

PMID:
19546411
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

PMID:
17999842
[PubMed - indexed for MEDLINE]
Free Article
9.

PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.

Valentine WJ, Bottomley JM, Palmer AJ, Brändle M, Foos V, Williams R, Dormandy JA, Yates J, Tan MH, Massi-Benedetti M; PROactive Study Group.

Diabet Med. 2007 Sep;24(9):982-1002. Epub 2007 Jun 25.

PMID:
17593245
[PubMed - indexed for MEDLINE]
10.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

PMID:
17049139
[PubMed - indexed for MEDLINE]
Free Article
11.

A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.

Chang RW, Pellisier JM, Hazen GB.

JAMA. 1996 Mar 20;275(11):858-65.

PMID:
8596224
[PubMed - indexed for MEDLINE]
12.

Placing a price on medical device innovation: the example of total knee arthroplasty.

Suter LG, Paltiel AD, Rome BN, Solomon DH, Thornhill TS, Abrams SK, Katz JN, Losina E.

PLoS One. 2013 May 6;8(5):e62709. doi: 10.1371/journal.pone.0062709. Print 2013.

PMID:
23671626
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
14.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

PMID:
16904047
[PubMed - indexed for MEDLINE]
Free Article
15.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.

Haentjens P, De Groote K, Annemans L.

Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. Epub 2004 Sep 10.

PMID:
15365714
[PubMed - indexed for MEDLINE]
16.

Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(10):1-66. Epub 2005 Jun 1.

PMID:
23074461
[PubMed]
Free PMC Article
17.

Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.

Tunis SL, Willis WD, Foos V.

Curr Med Res Opin. 2010 Jan;26(1):163-75. doi: 10.1185/03007990903429765.

PMID:
19919377
[PubMed - indexed for MEDLINE]
18.

A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.

McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S.

Health Technol Assess. 2010 May;14(24):1-162. doi: 10.3310/hta14240. Review.

PMID:
20492762
[PubMed - indexed for MEDLINE]
Free Article
19.

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D.

Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. Review.

PMID:
16796930
[PubMed - indexed for MEDLINE]
Free Article
20.

Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis.

Cochrane T, Davey RC, Matthes Edwards SM.

Health Technol Assess. 2005 Aug;9(31):iii-iv, ix-xi, 1-114.

PMID:
16095546
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk